“…Multiple transporters have been advanced as direct or indirect activators of the mTORC1 pathway including SNAT2 (slc38a2) (Evans et al, 2007;Hyde et al, 2007;Evans et al, 2008), SNAT9 (slc38a9) (Rebsamen et al, 2015;Wang et al, 2015), LAT1-4F2hc (slc7a5-slc3a2) (Fuchs et al, 2007;Nicklin et al, 2009), ASCT2 (slc1a5) (Fuchs et al, 2007;Nicklin et al, 2009), PAT1 (slc36a1) (Heublein et al, 2010;Zoncu et al, 2011;Wu et al, 2016;Zhao et al, 2019) and PAT4 (slc36a4) (Heublein et al, 2010;Fan et al, 2016;Zheng et al, 2016). A number of studies have now firmly established that SNAT9 is a lysosomal arginine sensor for mTORC1 (Jung et al, 2015;Rebsamen et al, 2015;Wang et al, 2015;Rebsamen and Superti-Furga, 2016;Wyant et al, 2017) by direct interaction of the transport N-terminal with the Rag GTPase-Ragulator-FLCN:FNIP2 complex upon arginine sensing (Fromm et al, 2020;Lei et al, 2020). Another widely proposed mechanism is glutamine accumulation by ASCT2, followed by its exchange for leucine import via LAT1-4F2hc (Fuchs et al, 2007;Nicklin et al, 2009).…”